The Drug Enforcement Administration last week published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients and Communities Act of 2018.

Effective Oct. 30, the rule allows certain practitioners to treat more patients; permanently adds nurse practitioners and physician assistants to the definition of “qualifying other practitioner”; and permits practitioners to complete required opioid training in medical school or residency as well as post-residency.

DEA will accept comments on the rule through Jan. 4.

DEA also will accept comments through Jan. 4 on a proposed rule implementing requirements to report suspicious orders of controlled substances under the Preventing Drug Diversion Act of 2018. The rule would offer multiple options for reporting suspicious orders; establish a centralized database for reporting; define key terms; and require specific record-keeping practices.

Related News Articles

Headline
The Senate Sept. 19 failed to adopt a continuing resolution by a 44-48 vote  that would have funded the government through Nov. 21. The CR was passed by…
Perspective
Public
All of America’s hospitals and health systems, regardless of ownership status, size or location, provide a vast range of benefits, programs and essential…
Headline
Corey Feist, CEO and co-founder of the Dr. Lorna Breen Heroes Foundation, and Tiffany Lyttle, R.N., director of cultural integration at Centra Health, discuss…
Headline
The House Appropriations Committee today released bill text for a continuing resolution to fund the government through Nov. 21. The bill also extends key…
Blog
Public
Medical residency is one of the most demanding stages in a physician’s career. Long hours, intense learning and new responsibilities often push trainees to…
Headline
The AHA Sept. 15 expressed support for the Ensuring Access to Essential Providers Act, legislation that would require Medicare Advantage plans to cover…